Clinical Trial Update: Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating etanercept for active axial ankylosing spondylitis completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED | Results posted: 2010-06-15